Results 111 to 120 of about 1,866,320 (298)

Elliptic Biorthogonal Polynomials Connected with Hermite's Continued Fraction

open access: yesSymmetry, Integrability and Geometry: Methods and Applications, 2007
We study a family of the Laurent biorthogonal polynomials arising from the Hermite continued fraction for a ratio of two complete elliptic integrals. Recurrence coefficients, explicit expression and the weight function for these polynomials are obtained.
Luc Vinet, Alexei Zhedanov
doaj  

On the analytic extension of three ratios of Horn's confluent hypergeometric function $\mathrm{H}_7$

open access: yesResearches in Mathematics
In this paper, we consider the extension of the analytic functions of two variables by special families of functions — continued fractions. In particular, we establish new symmetric domains of the analytical continuation of three ratios of Horn's ...
V. Hladun, R. Rusyn, M. Dmytryshyn
doaj   +1 more source

Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment

open access: yesMolecular Oncology, EarlyView.
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley   +1 more source

Some new continued fraction sequence convergent to the Somos quadratic recurrence constant

open access: yesJournal of Inequalities and Applications, 2016
In this paper, we provide some new continued fraction approximation and inequalities of the Somos quadratic recurrence constant, using its relation with the generalized Euler constant.
Xu You, Shouyou Huang, Di-Rong Chen
doaj   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

On univalence of a continued fraction [PDF]

open access: yesPacific Journal of Mathematics, 1960
Merkes, E. P., Scott, W. T.
openaire   +2 more sources

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

open access: yesMolecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis   +3 more
wiley   +1 more source

Golden Ratio and a Ramanujan-Type Integral

open access: yesAxioms, 2013
In this paper, we give a pedagogical introduction to several beautiful formulas discovered by Ramanujan. Using these results, we evaluate a Ramanujan-type integral formula. The result can be expressed in terms of the Golden Ratio.
Hei-Chi Chan
doaj   +1 more source

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

open access: yesMolecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim   +3 more
wiley   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

open access: yesMolecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy